The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.
第一作者:
H J,Müller
第一单位:
Department of Physiological Chemistry, University of Marburg, Germany.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);色谱法, 高压液相(Chromatography, High Pressure Liquid);剂量效应关系, 药物(Dose-Response Relationship, Drug);多柔比星(Doxorubicin);表柔比星(Epirubicin);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);肝(Liver);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies)
DOI
10.5414/cpp40575
PMID
12503820
发布时间
2019-06-07
- 浏览80
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



